Fangwen Zou
- Co-authors
- Anusha Shirwaikar ThomasYinghong WangChunhong HuIsabella C. Glitza OlivaJinan MaJohn A. ThompsonJennifer L. McQuadeHao Chi Zhang
- Topics
- Cancer Immunotherapy and Biomarkers (9 papers)Microscopic Colitis (7 papers)Inflammatory Bowel Disease (5 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Fangwen Zou
25 papers receiving 341 citations
Peers
Comparison fields: 5 of 63
- Oncology 214
- Molecular Biology 86
- Epidemiology 67
- Pulmonary and Respiratory Medicine 66
- Cancer Research 60
Countries citing papers authored by Fangwen Zou
This map shows the geographic impact of Fangwen Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangwen Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangwen Zou more than expected).
Fields of papers citing papers by Fangwen Zou
This network shows the impact of papers produced by Fangwen Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangwen Zou. The network helps show where Fangwen Zou may publish in the future.
Co-authorship network of co-authors of Fangwen Zou
This figure shows the co-authorship network connecting the top 25 collaborators of Fangwen Zou. A scholar is included among the top collaborators of Fangwen Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangwen Zou. Fangwen Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 17 | |
| 3 | 17 | |
| 4 | 9 | |
| 5 | 25 | |
| 6 | 4 | |
| 7 | 10 | |
| 8 | 1 | |
| 9 | 24 | |
| 10 | 12 | |
| 11 | 25 | |
| 12 | 2 | |
| 13 | 1 | |
| 14 | 5 | |
| 15 | Decitabine reverses gefitinib resistance in PC9 lung adenocarcinoma cells by demethylation of RASSF1A and GADD45β promoter. | 14 |
| 16 | 2 | |
| 17 | 17 | |
| 18 | 6 | |
| 19 | 2 | |
| 20 | 1 |
About Fangwen Zou
Fangwen Zou is a scholar working on Health Informatics, Oncology and Epidemiology, having authored 25 papers that have together received 344 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Microscopic Colitis (7 papers) and Inflammatory Bowel Disease (5 papers). The work is most often cited by research in Health Informatics (12 citations), Oncology (214 citations) and Cancer Research (60 citations). Fangwen Zou has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Anusha Shirwaikar Thomas, Yinghong Wang, Chunhong Hu, Isabella C. Glitza Oliva, Jinan Ma, John A. Thompson, Jennifer L. McQuade, Hao Chi Zhang, Xuemei Wang and Chaoyuan Liu. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.